EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of advanced breast cancer vinorelbine and docetaxel +- human granulocyte colony-stimulating factor



Treatment of advanced breast cancer vinorelbine and docetaxel +- human granulocyte colony-stimulating factor



European Journal of Cancer 36(Supplement 5): S91, September




(PDF 0-2 workdays service: $29.90)

Accession: 035980855

Download citation: RISBibTeXText



Related references

Treatment of advanced breast cancer with vinorelbine and docetaxel + human granulocyte colony-stimulating factor. Onkologie 23(Sonderheft 7): 10, October, 2000

Treatment of advanced breast cancer with vinorelbine and docetaxel with or without human granulocyte colony-stimulating factor. Journal of Clinical Oncology 19(3): 621-627, 2001

Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony-stimulating factor. Breast Cancer Research & Treatment 55(3): 203-211, June, 1999

Treatment of advanced breast cancer with taxotere and vinorelbine +- human granulocyte colony-stimulating factor. European Journal of Cancer 35(SUPPL 4): S321, Sept, 1999

Treatment of advanced breast cancer with vinorelbine , fluorouracil , L-leucovorin , and human granulocyte colony-stimulating factor. European Journal of Cancer 32A(SUPPL 1): S20, 1996

Effective treatment of advanced breast cancer with vinorelbine, mitomycin C plus human granulocyte colony-stimulating factor. British Journal of Cancer 74(10): 1668-1673, 1996

Effective treatment of advanced breast cancer with vinorelbine, 5-fluorouracil and I-leucovorin plus human granulocyte colony-stimulating factor. British Journal of Cancer 78(5): 673-678, Sept, 1998

Treatment of advanced breast cancer with docetaxel and gemcitabine with and without human granulocyte colony-stimulating factor. Clinical Cancer Research 8(5): 1051-1056, 2002

Phase I study of vinorelbine and docetaxel with granulocyte colony-stimulating factor support in the treatment of metastatic breast cancer. Cancer Investigation 20(1): 29-37, January, 2002

Treatment of advanced, refractory breast cancer with alternating docetaxel and epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factor. Breast Cancer Research & Treatment 63(3): 235-241, October, 2000

Biweekly docetaxel and vinorelbine with granulocyte colony-stimulating factor support for patients with anthracycline-resistant metastatic breast cancer. Anti-Cancer Drugs 16(1): 77-82, 2004

Biweekly docetaxel and vinorelbine with granulocyte colony-stimulating factor support for patients with anthracycline-resistant metastatic breast cancer. Anti Cancer Drugs 16(1): 77-82, 2005

Docetaxel and epirubicin supported by granulocyte colony-stimulating factor first-line in advanced breast cancer. Anticancer Research 23(3c): 2917-2923, 2003